Caldwell Trust’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$36.1K Hold
192
﹤0.01% 530
2025
Q4
$36.3K Hold
192
﹤0.01% 516
2025
Q3
$31.8K Sell
192
-33
-15% -$5.38K ﹤0.01% 526
2025
Q2
$34.5K Hold
225
﹤0.01% 502
2025
Q1
$35.4K Hold
225
﹤0.01% 493
2024
Q4
$35.3K Hold
225
﹤0.01% 487
2024
Q3
$39.9K Hold
225
﹤0.01% 482
2024
Q2
$37.9K Sell
225
-200
-47% -$32.7K ﹤0.01% 477
2024
Q1
$70.7K Hold
425
0.01% 418
2023
Q4
$70.3K Hold
425
0.01% 408
2023
Q3
$66.2K Hold
425
0.01% 403
2023
Q2
$66.3K Hold
425
0.01% 409
2023
Q1
$68.9K Hold
425
0.01% 392
2022
Q4
$67.9K Hold
425
0.01% 385
2022
Q3
$59.8K Hold
425
0.01% 406
2022
Q2
$62K Hold
425
0.01% 418
2022
Q1
$68.9K Hold
425
0.01% 414
2021
Q4
$80.5K Hold
425
0.01% 399
2021
Q3
$85.9K Hold
425
0.01% 378
2021
Q2
$85.7K Hold
425
0.01% 382
2021
Q1
$74.6K Hold
425
0.01% 388
2020
Q4
$72.1K Hold
425
0.01% 374
2020
Q3
$68.9K Sell
425
-100
-19% -$16.3K 0.01% 372
2020
Q2
$85.5K Hold
525
0.01% 357
2020
Q1
$67.2K Sell
525
-150
-22% -$20.2K 0.01% 375
2019
Q4
$94.1K Buy
+675
New +$88.7K 0.01% 371

Other funds holding BBH

Caldwell Trust's BBH Position: Q1 2026 in Review

Caldwell Trust held its VanEck Biotech ETF (BBH) position steady in Q1 2026 at 192 shares worth $36.1K. The position accounts for ﹤0.01% of the portfolio, ranked #530.

Caldwell Trust first reported a position in BBH in Q4 2019 and has held it in 26 quarters since. The position peaked at $94.1K in Q4 2019. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

  • Caldwell Trust held 192 shares of VanEck Biotech ETF worth $36.1K as of Q1 2026.
  • Caldwell Trust left its VanEck Biotech ETF share count unchanged in Q1 2026.
  • VanEck Biotech ETF made up ﹤0.01% of Caldwell Trust's portfolio in Q1 2026, its #530 holding.
  • Caldwell Trust first reported a position in VanEck Biotech ETF in Q4 2019 and has held it in 26 quarters since.
  • Caldwell Trust's VanEck Biotech ETF position peaked at $94.1K in Q4 2019.
  • 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Caldwell Trust's 13F filing for Q1 2026, filed 22 Apr 2026.